What medication can be used to lower heart rate (HR) and blood pressure (BP)?

Medication to Decrease Heart Rate and Blood Pressure

Beta-blockers are the primary medication class that effectively reduces both heart rate and blood pressure simultaneously. Among beta-blockers, carvedilol, metoprolol succinate, and bisoprolol are specifically recommended as they have proven outcomes in reducing both parameters 1.

First-Line Beta-Blocker Options

The following beta-blockers effectively lower both HR and BP:

• Carvedilol (12.5-50 mg twice daily): Combined alpha- and beta-receptor blocker with proven cardiovascular benefits 1, 2
• Metoprolol succinate (50-200 mg once daily): Cardioselective beta-blocker with sustained release 1, 2
• Bisoprolol (2.5-10 mg once daily): Cardioselective with proven outcomes 1

Beta-blockers reduce heart rate by approximately 10-12 beats per minute at standard doses 3, 4, while simultaneously lowering blood pressure by 6/4 mmHg at starting doses and 8/6 mmHg at double the starting dose 3.

Clinical Context for Beta-Blocker Use

Beta-blockers are particularly indicated when there are compelling cardiovascular conditions 5:

• Post-myocardial infarction (Class I recommendation) 6
• Heart failure with reduced ejection fraction 1
• Stable angina pectoris 6
• Atrial fibrillation requiring rate control 7
• Ischemic heart disease 6

Important Caveat

Beta-blockers are NOT recommended as first-line therapy for uncomplicated hypertension in patients ≥60 years old 8. However, they remain essential when the above compelling indications exist.

Alternative Medications That Lower Both HR and BP

Non-Dihydropyridine Calcium Channel Blockers

Diltiazem and verapamil effectively reduce both heart rate and blood pressure 7:

• Diltiazem: 15-20 mg IV over 2 minutes (acute setting) or oral maintenance 5-15 mg/h 7
• Verapamil: 2.5-5 mg IV over 2 minutes, may repeat to total 20-30 mg 7

Critical Warning: These agents should be avoided in patients with heart failure 1 and should only be used in narrow-complex tachycardias 7.

Centrally Acting Agents

Clonidine reduces both BP and HR through central alpha-2 agonist effects 9:

• Reduces BP oscillations and heart rate variability 9
• Oral: 0.1-0.8 mg twice daily 2
• Reserved as last-line therapy due to significant CNS side effects, especially in older adults 2
• Must be tapered to avoid rebound hypertension 2

Practical Treatment Algorithm

For Patients WITH Compelling Indications (CAD, HF, post-MI):

1. Start with beta-blocker (carvedilol, metoprolol succinate, or bisoprolol) 1
2. Add ACE inhibitor or ARB 1
3. Add diuretic if needed 1

For Patients WITHOUT Compelling Indications:

1. Start with ACE inhibitor/ARB + calcium channel blocker (dihydropyridine) + thiazide-like diuretic 5, 10
2. Add beta-blocker as fourth-line agent if BP/HR control inadequate 5, 10

For Acute Settings (Hypertensive Emergencies):

• Esmolol: 0.5 mg/kg IV bolus, then 50-300 mcg/kg/min infusion 11
• Labetalol: 0.25-0.5 mg/kg IV bolus or 2-4 mg/min infusion 11
• Metoprolol: 2.5-5 mg IV over 2 minutes, repeat every 5 minutes to maximum 15 mg 7, 11

Common Pitfalls to Avoid

1. Do not use beta-blockers in patients with:

   • Asthma or severe COPD 7, 2
   • Decompensated heart failure (acute setting) 7
   • Second or third-degree AV block without pacemaker 7, 11
   • Severe bradycardia (HR <50 bpm) 7

2. Avoid combining non-dihydropyridine CCBs with beta-blockers due to excessive bradycardia and AV block risk 8

3. Never abruptly discontinue beta-blockers - taper to prevent rebound hypertension and tachycardia 2

4. Monitor for excessive diastolic BP reduction (<60 mmHg) in elderly patients or those with diabetes, as this may worsen myocardial ischemia 1